Email
Print
1. AntiCoagulants Market - Overview
1.1 Definitions and Scope
2. AntiCoagulants Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. AntiCoagulants Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. AntiCoagulants Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. AntiCoagulants Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. AntiCoagulants Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. AntiCoagulants Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. AntiCoagulants Market - By Drug Class (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
8.3.1 NOACs
8.3.2 Heparins & LMWH
8.3.3 Vitamin K Antagonists
8.3.4 Other Anticoagulant Drugs
9. AntiCoagulants Market - By Route Of Administration (Market Size -$Million / $Billion)
9.1 Oral Anticoagulants
9.2 Injectable Anticoagulants
10. AntiCoagulants - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 Atrial Fibrillation & Heart Attack
10.3.2 Stroke
10.3.3 Deep Vein Thrombosis (DVT)
10.3.4 Pulmonary Embolism (PE)
10.3.5 Others
11. AntiCoagulants- By Geography (Market Size -$Million / $Billion)
11.1 AntiCoagulants Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 AntiCoagulants- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 AntiCoagulants- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 AntiCoagulants - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 AntiCoagulants - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. AntiCoagulants Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. AntiCoagulants Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. AntiCoagulants Market - Key Company List by Country Premium
15. AntiCoagulants Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Abbott Laboratory
15.3 Astrazeneca
15.4 Aurobindo Pharma Ltd
15.5 Biocon
15.6 Concord Biotech
15.7 Glaxosmithkline Plc
15.8 Merck Co Inc
15.9 Novartis Global
15.10 Pfizer Inc
15.11 Sun Pharma
15.12 Company 12
15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. AntiCoagulants Market - Appendix
16.1 Abbreviations
16.2 Sources
17. AntiCoagulants Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Anticoagulant Market, By Type Market 2023-2030 ($M)1.1 Betrixaban Market 2023-2030 ($M) - Global Industry Research
1.2 Dabigatran Market 2023-2030 ($M) - Global Industry Research
1.3 Edoxaban Market 2023-2030 ($M) - Global Industry Research
1.4 Rivaroxaban Market 2023-2030 ($M) - Global Industry Research
1.5 Eliquis Market 2023-2030 ($M) - Global Industry Research
2.Global Anticoagulant Market, By Type Market 2023-2030 (Volume/Units)
2.1 Betrixaban Market 2023-2030 (Volume/Units) - Global Industry Research
2.2 Dabigatran Market 2023-2030 (Volume/Units) - Global Industry Research
2.3 Edoxaban Market 2023-2030 (Volume/Units) - Global Industry Research
2.4 Rivaroxaban Market 2023-2030 (Volume/Units) - Global Industry Research
2.5 Eliquis Market 2023-2030 (Volume/Units) - Global Industry Research
3.North America Anticoagulant Market, By Type Market 2023-2030 ($M)
3.1 Betrixaban Market 2023-2030 ($M) - Regional Industry Research
3.2 Dabigatran Market 2023-2030 ($M) - Regional Industry Research
3.3 Edoxaban Market 2023-2030 ($M) - Regional Industry Research
3.4 Rivaroxaban Market 2023-2030 ($M) - Regional Industry Research
3.5 Eliquis Market 2023-2030 ($M) - Regional Industry Research
4.South America Anticoagulant Market, By Type Market 2023-2030 ($M)
4.1 Betrixaban Market 2023-2030 ($M) - Regional Industry Research
4.2 Dabigatran Market 2023-2030 ($M) - Regional Industry Research
4.3 Edoxaban Market 2023-2030 ($M) - Regional Industry Research
4.4 Rivaroxaban Market 2023-2030 ($M) - Regional Industry Research
4.5 Eliquis Market 2023-2030 ($M) - Regional Industry Research
5.Europe Anticoagulant Market, By Type Market 2023-2030 ($M)
5.1 Betrixaban Market 2023-2030 ($M) - Regional Industry Research
5.2 Dabigatran Market 2023-2030 ($M) - Regional Industry Research
5.3 Edoxaban Market 2023-2030 ($M) - Regional Industry Research
5.4 Rivaroxaban Market 2023-2030 ($M) - Regional Industry Research
5.5 Eliquis Market 2023-2030 ($M) - Regional Industry Research
6.APAC Anticoagulant Market, By Type Market 2023-2030 ($M)
6.1 Betrixaban Market 2023-2030 ($M) - Regional Industry Research
6.2 Dabigatran Market 2023-2030 ($M) - Regional Industry Research
6.3 Edoxaban Market 2023-2030 ($M) - Regional Industry Research
6.4 Rivaroxaban Market 2023-2030 ($M) - Regional Industry Research
6.5 Eliquis Market 2023-2030 ($M) - Regional Industry Research
7.MENA Anticoagulant Market, By Type Market 2023-2030 ($M)
7.1 Betrixaban Market 2023-2030 ($M) - Regional Industry Research
7.2 Dabigatran Market 2023-2030 ($M) - Regional Industry Research
7.3 Edoxaban Market 2023-2030 ($M) - Regional Industry Research
7.4 Rivaroxaban Market 2023-2030 ($M) - Regional Industry Research
7.5 Eliquis Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)2.Canada U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
3.Mexico U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
4.Brazil U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
5.Argentina U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
6.Peru U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
7.Colombia U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
8.Chile U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
9.Rest of South America U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
10.UK U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
11.Germany U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
12.France U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
13.Italy U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
14.Spain U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
15.Rest of Europe U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
16.China U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
17.India U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
18.Japan U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
19.South Korea U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
20.South Africa U.S. AntiCoagulants Market Revenue, 2023-2030 ($M)
21.North America U.S. AntiCoagulants By Application
22.South America U.S. AntiCoagulants By Application
23.Europe U.S. AntiCoagulants By Application
24.APAC U.S. AntiCoagulants By Application
25.MENA U.S. AntiCoagulants By Application
26.Pfizer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Astrazeneca, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Novartis Global, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Merck Co Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Biocon, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Glaxosmithkline Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Concord Biotech, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Aurobindo Pharma Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Sun Pharma, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Abbott Laboratory, Sales /Revenue, 2015-2018 ($Mn/$Bn)